(Q43198800)

15 November 2017

title

Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures (English)

1 reference

15 November 2017

1 reference

Claudia Ganser

1

1 reference

15 November 2017

Anna Papazoglou

series ordinal

2

1 reference

15 November 2017

Lothar Just

series ordinal

3

1 reference

15 November 2017

Guido Nikkhah

series ordinal

4

1 reference

15 November 2017

language of work or name

English

0 references

publication date

11 January 2010

1 reference

Experimental Cell Research

15 November 2017

published in

1 reference

15 November 2017

volume

316

1 reference

15 November 2017

issue

5

1 reference

15 November 2017

page(s)

737-746

1 reference

A human stromal-based serum-free culture system supports the ex vivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/progenitor cells

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Animal models of neurological deficits: how relevant is the rat?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Comparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: evidence for interhemispheric functional coupling of the two nigrostriatal pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

6-hydroxy-dopamine induced degeneration of central monoamine neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Green fluorescent protein as a marker for gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

6-hydroxydopamine-induced nuclear factor-kappa B activation in PC12 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

6-hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Catecholamine toxicity in cerebral cortex in dissociated cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Autoxidation and Neurotoxicity of 6-Hydroxydopamine in the Presence of Some Antioxidants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Role of the kidney in erythropoiesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Localization of specific erythropoietin binding sites in defined areas of the mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Erythropoietin in the brain: can the promise to protect be fulfilled?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Erythropoietin and the hypoxic brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Recent trends in erythropoietin-mediated neuroprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Effects of erythropoietin on neuronal activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Erythropoietin and bone morphogenetic protein 7 mediate ascorbate-induced dopaminergic differentiation from embryonic mesencephalic precursors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Erythropoietin receptor is expressed on adult rat dopaminergic neurons and erythropoietin is neurotrophic in cultured dopaminergic neuroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Erythropoietin protects against 6-hydroxydopamine-induced dopaminergic cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Autoradiographic demonstration of uptake and accumulation of3H-6-hydroxydopamine in adrenergic nerves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Glial cell line derived neurotrophic factor promotes the recovery of dopamine neurons damaged by 6-hydroxydopamine in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Erythropoietin promotes regeneration of adult CNS neurons via Jak2/Stat3 and PI3K/AKT pathway activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Erythropoietin after focal cerebral ischemia activates the Janus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Conditional gene ablation of Stat3 reveals differential signaling requirements for survival of motoneurons during development and after nerve injury in the adult

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

JAKs, STATs and Src kinases in hematopoiesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Activation of the Akt/FKHRL1 pathway mediates the antiapoptotic effects of erythropoietin in primary human erythroid progenitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Protective effect of platelet-derived growth factor against 6-hydroxydopamine-induced lesion of rat dopaminergic neurons in culture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Platelet-derived growth factor promotes survival of rat and human mesencephalic dopaminergic neurons in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

The response of human and rat fetal ventral mesencephalon in culture to the brain-derived neurotrophic factor treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

Emerging restorative treatments for Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.001

10.1016/J.YEXCR.2010.01.001

7 January 2021

Identifiers

DOI

1 reference

15 November 2017

1 reference